Xalkori 200 mg – DIN 02384256
Xalkori is Crizotinib 200 mg (capsule), sold in Canada. It is used for lung cancer. It is supplied by Pfizer Canada ULC. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Crizotinib 200 mg
- Brand
- Xalkori
- Strength
- 200 mg
- Used for
- Lung cancer
- Form
- Capsule
- Manufacturer
- Pfizer Canada ULC
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02384256
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Crizotinib used for?
Crizotinib is used for lung cancer.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
ALK- or ROS1-Positive Metastatic Non-Small Cell Lung Cancer
XALKORI is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test.
Relapsed or Refractory, Systemic ALK-Positive Anaplastic Large Cell Lymphoma
XALKORI is indicated for the treatment of pediatric patients 1 year of age and older and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive.
Limitations of Use: The safety and efficacy of XALKORI have not been established in older adults with relapsed or refractory, systemic ALK-positive ALCL.
Unresectable, Recurrent, or Refractory ALK-Positive Inflammatory Myofibroblastic Tumor
XALKORI is indicated for the treatment of adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory myofibroblastic tumor (IMT) that is ALK-positive.
From the FDA-approved label on DailyMed (published Jul 24, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02384256.
- It names Xalkori, Crizotinib 200 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Xalkori by Pfizer Canada ULC.
In Canada: prescription only.
Ingredients
Active: Crizotinib
Other Crizotinib pills
- Pfizer CRZ 150 Crizotinib 150 mg Blue, capsule, 22 mm Used for lung cancer
- Pfizer CRZ 20 Crizotinib 20 mg Blue & white, capsule, 15 mm Used for lung cancer
- Pfizer CRZ 200 Crizotinib 200 mg Pink & white, capsule, 19 mm Used for lung cancer
- Pfizer CRZ 250 Crizotinib 250 mg Pink, capsule, 21 mm Used for lung cancer
- Pfizer CRZ 50 Crizotinib 50 mg Gray, capsule, 16 mm Used for lung cancer
- No picture yet DIN 02384264 Crizotinib 250 mg Xalkori, Capsule, sold in Canada Used for lung cancer